Crohn's Disease Clinical Trials in Mentor, Ohio

4 studies are recruiting for crohn's disease in Mentor, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinica…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor, Ohio
    Locations
    499 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06430801 on ClinicalTrials.gov

  2. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 month…

    Stage
    Phase 4
    Ages
    18 to 80
    Site
    Great Lakes Gastroenterology Research, LLC, Mentor, Ohio
    Locations
    101 in total
    Run by
    Takeda

    See if you can join NCT06581328 on ClinicalTrials.gov

  3. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual …

    Stage
    Phase 4
    Ages
    18 to 70
    Site
    Great Lakes Gastroenterology Research, LLC, Mentor, Ohio
    Locations
    48 in total
    Run by
    Takeda

    See if you can join NCT06045754 on ClinicalTrials.gov

  4. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study i…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Great Lakes Gastroenterology Research, LLC, Mentor, Ohio
    Locations
    190 in total
    Run by
    Takeda

    See if you can join NCT06233461 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.